These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Hepatitis and multi-drug therapy in leprosy with special reference to prothionamide. Kar HK; Balakrishnan S; Vasantha Kumar G; Sirumban P; Roy RG Indian J Lepr; 1985; 57(1):78-89. PubMed ID: 3839828 [TBL] [Abstract][Full Text] [Related]
63. A study of drug interactions in leprosy--1. Effect of simultaneous administration of prothionamide on metabolic disposition of rifampicin and dapsone. Mathur A; Venkatesan K; Girdhar BK; Bharadwaj VP; Girdhar A; Bagga AK Lepr Rev; 1986 Mar; 57(1):33-7. PubMed ID: 3702578 [No Abstract] [Full Text] [Related]
65. [Protionamide in the treatment of pulmonary tuberculosis]. Kalabukha AV; Bialik IB; Mamolat AS Vrach Delo; 1972 May; 5():31-3. PubMed ID: 5029793 [No Abstract] [Full Text] [Related]
66. Effects of ethionamide (TH-1314) and prothionamide (TH-1321) on gastric juice acidity. Gupta DK; Agarwal MC; Mittal OP Indian J Chest Dis; 1974 Jul; 16(3):163-70. PubMed ID: 4418691 [No Abstract] [Full Text] [Related]
67. [Treatment of lepromatous leprosy by ethionamide]. Rollier R; Rollier M Maroc Med; 1972 Mar; 52(555):148-66. PubMed ID: 4261347 [No Abstract] [Full Text] [Related]
68. Treatment of leprosy using combination therapy--but how? Freerksen E Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):407-8. PubMed ID: 6685704 [No Abstract] [Full Text] [Related]
69. [The hepatotoxicity of ethionamide remains a topical subject. Apropos of a case of acute hepatitis]. See A; Hervio P; Bouvry M Ann Gastroenterol Hepatol (Paris); 1986; 22(3):129-30. PubMed ID: 3729286 [TBL] [Abstract][Full Text] [Related]
70. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis]. Homenko AG; Ciukanov VL Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302 [TBL] [Abstract][Full Text] [Related]
71. Side effects and toxicity of ethionamide and prothionamide. Tala E; Tevola K Ann Clin Res; 1969 May; 1(1):32-5. PubMed ID: 5350768 [No Abstract] [Full Text] [Related]
72. Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin. Cartel JL; Naudillon Y; Artus JC; Grosset JH Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):15-8. PubMed ID: 3998559 [TBL] [Abstract][Full Text] [Related]
73. The treatment of tuberculosis. Springett VH Practitioner; 1975 Oct; 215(1288):480-6. PubMed ID: 53832 [No Abstract] [Full Text] [Related]
74. [Application of rapid polarography with overimposed alternating current to the study of urinary elimination of ethionamide and prothionamide metabolites in humans]. Bieder A; Brunel P Ann Pharm Fr; 1971; 29(9):461-75. PubMed ID: 5129579 [No Abstract] [Full Text] [Related]
75. [Clinical study on hepatic disturbance during ethionamide or prothionamide treatment. Comparative study by using the same type of preparation of both drugs]. Osato T Kekkaku; 1971 Sep; 46(9):345-9. PubMed ID: 5122003 [No Abstract] [Full Text] [Related]
76. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project. Jacobson RR; Gatt P Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987 [TBL] [Abstract][Full Text] [Related]
77. Multidrug therapy (MDT) and leprosy control. Noordeen SK Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680 [No Abstract] [Full Text] [Related]
79. Comparison of the clinical usefulness of ethionamide and prothionamide in initial treatment of tuberculosis: tenth series of controlled trials. Tubercle; 1968 Sep; 49(3):281-90. PubMed ID: 4884773 [No Abstract] [Full Text] [Related]
80. [Determination of prothionamide and ethionamide and their sulfoxides in blood plasma]. Pütter J Arzneimittelforschung; 1972 Jun; 22(6):1027-31. PubMed ID: 4262015 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]